TY - JOUR AU - Kwekkeboom, D. J. AU - Herder, W. W. AU - Eijck, C. H. AU - Kam, B. L. AU - Essen, M. AU - Teunissen, J. J. PY - 2010 DA - 2010// TI - Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors JO - Semin Nucl Med VL - 40 UR - https://doi.org/10.1053/j.semnuclmed.2009.10.004 DO - 10.1053/j.semnuclmed.2009.10.004 ID - Kwekkeboom2010 ER - TY - JOUR AU - Laverman, P. AU - Sosabowski, J. K. AU - Boerman, O. C. AU - Oyen, W. J. PY - 2012 DA - 2012// TI - Radiolabelled peptides for oncological diagnosis JO - Eur J Nucl Med Mol Imaging VL - 39 UR - https://doi.org/10.1007/s00259-011-2014-7 DO - 10.1007/s00259-011-2014-7 ID - Laverman2012 ER - TY - JOUR AU - Krenning, E. P. AU - Jong, M. AU - Kooij, P. P. AU - Breeman, W. A. AU - Bakker, W. H. AU - Herder, W. W. PY - 1999 DA - 1999// TI - Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy JO - Ann Oncol. VL - 10 UR - https://doi.org/10.1093/annonc/10.suppl_2.S23 DO - 10.1093/annonc/10.suppl_2.S23 ID - Krenning1999 ER - TY - JOUR AU - Yao, J. C. AU - Hassan, M. AU - Phan, A. AU - Dagohoy, C. AU - Leary, C. AU - Mares, J. E. PY - 2008 DA - 2008// TI - One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.4377 DO - 10.1200/JCO.2007.15.4377 ID - Yao2008 ER - TY - JOUR AU - Reubi, J. C. AU - Kvols, L. K. AU - Waser, B. AU - Nagorney, D. M. AU - Heitz, P. U. AU - Charboneau, J. W. PY - 1990 DA - 1990// TI - Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas JO - Cancer Res VL - 50 ID - Reubi1990 ER - TY - JOUR AU - Bodei, L. PY - 2011 DA - 2011// TI - Peptide receptor radionuclide therapy with (1)(7)(7)Lu-DOTATATE: the IEO phase I-II study JO - Eur J Nucl Med Mol Imaging VL - 38 UR - https://doi.org/10.1007/s00259-011-1902-1 DO - 10.1007/s00259-011-1902-1 ID - Bodei2011 ER - TY - JOUR AU - Rich, T. A. AU - Shepard, R. C. AU - Mosley, S. T. PY - 2004 DA - 2004// TI - Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.08.009 DO - 10.1200/JCO.2004.08.009 ID - Rich2004 ER - TY - JOUR AU - Claringbold, P. G. AU - Price, R. A. AU - Turner, J. H. PY - 2012 DA - 2012// TI - Phase I-II study of radiopeptide 177Lu-octreotate in combination with capecitabine and temozolomide in advanced low-grade neuroendocrine tumors JO - Cancer Biother Radiopharm VL - 27 UR - https://doi.org/10.1089/cbr.2012.1276 DO - 10.1089/cbr.2012.1276 ID - Claringbold2012 ER - TY - JOUR AU - Bobola, M. S. AU - Kolstoe, D. D. AU - Blank, A. AU - Silber, J. R. PY - 2010 DA - 2010// TI - Minimally cytotoxic doses of temozolomide produce radiosensitization in human glioblastoma cells regardless of MGMT expression JO - Mol Cancer Ther VL - 9 UR - https://doi.org/10.1158/1535-7163.MCT-10-0010 DO - 10.1158/1535-7163.MCT-10-0010 ID - Bobola2010 ER - TY - JOUR AU - Essen, M. AU - Krenning, E. P. AU - Kam, B. L. AU - Herder, W. W. AU - Aken, M. O. AU - Kwekkeboom, D. J. PY - 2008 DA - 2008// TI - Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours JO - Eur J Nucl Med Mol Imaging VL - 35 UR - https://doi.org/10.1007/s00259-007-0688-7 DO - 10.1007/s00259-007-0688-7 ID - Essen2008 ER - TY - JOUR AU - Fueger, B. J. AU - Hamilton, G. AU - Raderer, M. AU - Pangerl, T. AU - Traub, T. AU - Angelberger, P. PY - 2001 DA - 2001// TI - Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells JO - J Nucl Med VL - 42 ID - Fueger2001 ER - TY - STD TI - Nayak TK, Atcher RW, Prossnitz ER, Norenberg JP. Enhancement of somatostatin-receptor-targeted (177)Lu-[DOTA(0)-Tyr(3)]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation. Nucl Med Biol. 2008;35(6):673–8. ID - ref12 ER - TY - JOUR AU - Pasquier, E. AU - Tuset, M. P. AU - Street, J. AU - Sinnappan, S. AU - MacKenzie, K. L. AU - Braguer, D. PY - 2013 DA - 2013// TI - Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells JO - Angiogenesis VL - 16 UR - https://doi.org/10.1007/s10456-012-9321-x DO - 10.1007/s10456-012-9321-x ID - Pasquier2013 ER - TY - JOUR AU - Hirst, T. C. AU - Vesterinen, H. M. AU - Sena, E. S. AU - Egan, K. J. AU - Macleod, M. R. PY - 2013 DA - 2013// TI - Whittle IR Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted? JO - Br J Cancer VL - 108 UR - https://doi.org/10.1038/bjc.2012.504 DO - 10.1038/bjc.2012.504 ID - Hirst2013 ER - TY - JOUR AU - Palma, J. P. AU - Wang, Y. C. AU - Rodriguez, L. E. AU - Montgomery, D. AU - Ellis, P. A. AU - Bukofzer, G. PY - 2009 DA - 2009// TI - ABT-888 confers broad in vivo activity in combination with temozolomide in diverse tumors JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-1245 DO - 10.1158/1078-0432.CCR-09-1245 ID - Palma2009 ER - TY - JOUR AU - Kitange, G. J. AU - Carlson, B. L. AU - Schroeder, M. A. AU - Grogan, P. T. AU - Lamont, J. D. AU - Decker, P. A. PY - 2009 DA - 2009// TI - Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts JO - Neuro Oncol VL - 11 UR - https://doi.org/10.1215/15228517-2008-090 DO - 10.1215/15228517-2008-090 ID - Kitange2009 ER - TY - JOUR AU - Breeman, W. PY - 2007 DA - 2007// TI - Effects of quenchers on the radiochemical purity of 111In-labeled peptides JO - J Nucl Med VL - 48 ID - Breeman2007 ER - TY - JOUR AU - Korosec, F. R. AU - Frayne, R. AU - Grist, T. M. AU - Mistretta, C. A. PY - 1996 DA - 1996// TI - Time-resolved contrast-enhanced 3D MR angiography JO - Magn Reson Med VL - 36 UR - https://doi.org/10.1002/mrm.1910360304 DO - 10.1002/mrm.1910360304 ID - Korosec1996 ER - TY - STD TI - Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10(3):223–32. ID - ref19 ER - TY - JOUR AU - Weidensteiner, C. AU - Rausch, M. AU - McSheehy, P. M. AU - Allegrini, P. R. PY - 2006 DA - 2006// TI - Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T JO - J Magn Reson Imaging VL - 24 UR - https://doi.org/10.1002/jmri.20676 DO - 10.1002/jmri.20676 ID - Weidensteiner2006 ER - TY - STD TI - van Essen M, Krenning EP, Bakker, W. H, de Herder WW, van Aken MO, Kwekkeboom DJ. Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin. Eur J Nucl Med Mol Imaging. 2007;34(8):1219–27. ID - ref21 ER - TY - STD TI - Waldherr C, Pless M, Maecke HR, Haldemann A, Mueller-Brand J. The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study. Ann Oncol. 2001;12(7):941–5. ID - ref22 ER - TY - JOUR AU - Parisi, S. AU - Corsa, P. AU - Raguso, A. AU - Perrone, A. AU - Cossa, S. AU - Munafò, T. PY - 2015 DA - 2015// TI - Temozolomide and radiotherapy versus radiotherapy alone in high grade gliomas: a very long term comparative study and literature review JO - Biomed Res Int. VL - 2015 UR - https://doi.org/10.1155/2015/620643 DO - 10.1155/2015/620643 ID - Parisi2015 ER - TY - STD TI - Fine RL, Gulati AP, Krantz BA, Moss RA, Schreibman S, et al. Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience. Cancer Chemother Pharmacol. 2013;71(3):663–70. ID - ref24 ER - TY - STD TI - Ekeblad S, Sundin A, Janson ET, Welin S, Granberg D, Kindmark H, et al. Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. Clin Cancer Res. 2007;13(10):2986–91. ID - ref25 ER - TY - JOUR AU - Simon, G. R. AU - Wagner, H. PY - 2003 DA - 2003// TI - Small cell lung cancer JO - Chest VL - 123 UR - https://doi.org/10.1378/chest.123.1_suppl.259S DO - 10.1378/chest.123.1_suppl.259S ID - Simon2003 ER - TY - JOUR AU - Pietanza, M. C. AU - Kadota, K. AU - Huberman, K. AU - Sima, C. S. AU - Fiore, J. J. AU - Sumner, D. K. PY - 2012 DA - 2012// TI - Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2059 DO - 10.1158/1078-0432.CCR-11-2059 ID - Pietanza2012 ER - TY - JOUR AU - Schmitt, A. AU - Bernhardt, P. AU - Nilsson, O. AU - Ahlman, H. AU - Kolby, L. AU - Schmitt, J. PY - 2003 DA - 2003// TI - Biodistribution and dosimetry of 177Lu-labeled [DOTA0, Tyr3]octreotate in male nude mice with human small cell lung cancer JO - Cancer Biother Radiopharm VL - 18 UR - https://doi.org/10.1089/108497803322287682 DO - 10.1089/108497803322287682 ID - Schmitt2003 ER - TY - JOUR AU - Schmitt, A. AU - Bernhardt, P. AU - Nilsson, O. AU - Ahlman, H. AU - Kolby, L. AU - Maecke, H. R. PY - 2004 DA - 2004// TI - Radiation therapy of small cell lung cancer with 177Lu-DOTA-Tyr3-octreotate in an animal model JO - J Nucl Med VL - 45 ID - Schmitt2004 ER - TY - JOUR AU - Barber, T. W. AU - Hofman, M. S. AU - Thomson, B. N. AU - Hicks, R. J. PY - 2012 DA - 2012// TI - The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable JO - Eur J Surg Oncol VL - 38 UR - https://doi.org/10.1016/j.ejso.2011.08.129 DO - 10.1016/j.ejso.2011.08.129 ID - Barber2012 ER - TY - JOUR AU - Lam, T. AU - Hetherington, J. W. AU - Greenman, J. AU - Little, S. AU - Maraveyas, A. PY - 2007 DA - 2007// TI - Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth JO - Acta Oncol VL - 46 UR - https://doi.org/10.1080/02841860701373603 DO - 10.1080/02841860701373603 ID - Lam2007 ER - TY - JOUR AU - Kim, J. T. AU - Kim, J. S. AU - Ko, K. W. AU - Kong, D. S. AU - Kang, C. M. AU - Kim, M. H. PY - 2006 DA - 2006// TI - Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas JO - Oncol Rep VL - 16 ID - Kim2006 ER - TY - JOUR AU - Jain, R. K. PY - 2013 DA - 2013// TI - Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.46.3653 DO - 10.1200/JCO.2012.46.3653 ID - Jain2013 ER - TY - JOUR AU - Bol, K. AU - Haeck, J. C. AU - Groen, H. C. AU - Niessen, W. J. AU - Bernsen, M. R. AU - Jong, M. PY - 2013 DA - 2013// TI - Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model? JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0077076 DO - 10.1371/journal.pone.0077076 ID - Bol2013 ER - TY - JOUR AU - Bernhardt, P. AU - Oddstig, J. AU - Kolby, L. AU - Nilsson, O. AU - Ahlman, H. AU - Forssell-Aronsson, E. PY - 2007 DA - 2007// TI - Effects of treatment with (177)Lu-DOTA-Tyr(3)-octreotate on uptake of subsequent injection in carcinoid-bearing nude mice JO - Cancer Biother Radiopharm VL - 22 UR - https://doi.org/10.1089/cbr.2007.333 DO - 10.1089/cbr.2007.333 ID - Bernhardt2007 ER - TY - JOUR AU - Atallah, E. AU - Flaherty, L. PY - 2005 DA - 2005// TI - Treatment of metastatic malignant melanoma JO - Curr Treat Options Oncol VL - 6 UR - https://doi.org/10.1007/s11864-005-0002-5 DO - 10.1007/s11864-005-0002-5 ID - Atallah2005 ER - TY - JOUR AU - Sonveaux, P. AU - Végran, F. AU - Schroeder, T. AU - Wergin, M. C. AU - Verrax, J. AU - Rabbani, Z. N. PY - 2008 DA - 2008// TI - Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice JO - J Clin Invest VL - 118 ID - Sonveaux2008 ER - TY - STD TI - J, B., Radiation protection (Green Book). Chapter 4—biological effects of radiation. New Brunswick Power Corporation, 2001: p. 87–108. ID - ref38 ER -